Akebia Therapeutics profit margin AKBA

Gross, operating and net profit as a share of revenue over the last twelve months, from 2018.

Net margin, 12 months: −13.5%
Operating margin, 12 months: −6.9%
Net margin on a year earlier: +4.4 pts
Peer median: 11.6%

Over the twelve months to Jun 30, 2026, Akebia Therapeutics kept −13.5% of its revenue as net profit, with an operating margin of −6.9% and a gross margin of 79.6%.

The median for 10 large drugmakers of a similar size is 11.6%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal year	Net margin	Operating margin	Gross margin
FY2025	−2.3%	9.9%	83.3%
FY2024	−43.3%	−31.5%	60.6%
FY2023	−26.7%	−23.8%	61.9%
FY2022	n/a	n/a	n/a
FY2021	n/a	n/a	28.2%
FY2020	n/a	n/a	−0.2%
FY2019	−83.5%	−85.5%	56.6%
FY2018	−69.1%	−85.8%	n/a
FY2017	n/a	n/a	n/a
FY2016	n/a	n/a	n/a
FY2015	n/a	n/a	n/a
FY2014	n/a	n/a	n/a
FY2013	n/a	n/a	n/a

Quarter by quarter

Quarter	Ended	Net margin, 12 months	Change on a year	Operating margin
Q2 FY26	Jun 30, 2026	−13.5%	+4.4 pts	−6.9%
Q1 FY26	Mar 31, 2026	−8.8%	+15.7 pts	2.3%
Q4 FY25	Dec 31, 2025	−2.3%	+41.1 pts	9.9%
Q3 FY25	Sep 30, 2025	−7.1%	+20.0 pts	7.9%
Q2 FY25	Jun 30, 2025	−17.9%	+5.3 pts	0.4%
Q1 FY25	Mar 31, 2025	−24.5%	−1.5 pts	−11.9%
Q4 FY24	Dec 31, 2024	−43.3%	−16.7 pts	−31.5%
Q3 FY24	Sep 30, 2024	−27.1%	n/a	−20.5%
Q2 FY24	Jun 30, 2024	−23.2%	n/a	−20.2%
Q1 FY24	Mar 31, 2024	−23.0%	n/a	−19.0%
Q4 FY23	Dec 31, 2023	−26.7%	n/a	−23.8%
Q3 FY23	Sep 30, 2023	n/a	n/a	n/a

Against its peers

Companies in Drug Manufacturers - General nearest Akebia Therapeutics' size, closest first, today.

Company	Profit margin
AKBAAkebia Therapeutics	−13.5%
NATRNatures Sunshine Products	3.7%
LFVNLifevantage	2.8%
SPROSpero Therapeutics	15.7%
ARVNArvinas	2.9%
ATNMActinium Pharmaceuticals	n/m
PBYIPuma Biotechnology	11.6%
IRWDIronwood Pharmaceuticals	33.4%
ZVRAZevra Therapeutics	42.8%
CRMDCorMedix	40.5%
COLLCollegium Pharmaceutical	5.9%
Peer median	11.6%

Where Akebia Therapeutics ranks

#57of 84Large drugmakers with the highest profit margins

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Akebia Therapeutics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.